Literature DB >> 12629062

A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA.

Itsuro Yoshimi1, Akira Ohshima, Wakiko Ajiki, Hideaki Tsukuma, Tomotaka Sobue.   

Abstract

Trends in the incidence rate of lung cancer by histological type were examined, based on data from the Osaka Cancer Registry (OCR), Japan and the Surveillance, Epidemiology and End Results Program (SEER), USA. Among males, an increasing trend was observed for adenocarcinoma in both registries. In the OCR, the incidence rate of adenocarcinoma has recently overtaken that of squamous cell carcinoma, whereas in the SEER, adenocarcinoma had already taken the lead since 1990-93. For squamous cell carcinoma, the decreasing trends in the OCR were consistent with a previous study, whereas in the SEER, the decline was earlier and steeper. For small cell carcinoma, the incidence rate was leveling off in the OCR, whereas it was already in decline in the SEER. For large cell carcinoma, the decreasing trend began earlier in the SEER. Among females in both registries, the incidence rate of adenocaricinoma has clearly been on the increase, whereas in other histological types the incidence rates were decreasing or at least leveling off. As for the age-specific incidence rate, different patterns were observed between the two registries: in the OCR, the incidence rate was on the increase in older age groups such as 70-74 years and also in younger age groups such as 45-49 years, whereas it decreased in intermediate age groups such as 55-59. In contrast, stable decreasing trends were observed in the SEER, except for adenocarcinoma. The increase in incidence rate observed among younger age groups in the OCR should be carefully monitored.

Entities:  

Mesh:

Year:  2003        PMID: 12629062     DOI: 10.1093/jjco/hyg019

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  21 in total

Review 1.  [Current morphological diagnosis of malignant lung tumors].

Authors:  K Junker
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

2.  Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma.

Authors:  Xiaoying Wang; Ying Ju; M I Zhou; Xiaoli Liu; Chengjun Zhou
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

3.  [Small cell lung cancer: pathology and molecular pathology].

Authors:  K Junker; I Petersen
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

4.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

5.  Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center.

Authors:  Sumesh Kachroo; L Tong; Margaret R Spitz; Yun Xing; Kelly Merriman; Dakai K Zhu; John Fueger; Christopher I Amos; Carol J Etzel
Journal:  Cancer Detect Prev       Date:  2008-07-17

Review 6.  The role of cancer registries in cancer control.

Authors:  Donald Maxwell Parkin
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

7.  Polonium and lung cancer.

Authors:  Vincenzo Zagà; Charilaos Lygidakis; Kamal Chaouachi; Enrico Gattavecchia
Journal:  J Oncol       Date:  2011-06-23       Impact factor: 4.375

8.  Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.

Authors:  Jeffrey A Tsou; Janice S Galler; Kimberly D Siegmund; Peter W Laird; Sally Turla; Wendy Cozen; Jeffrey A Hagen; Michael N Koss; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2007-10-29       Impact factor: 27.401

9.  Filter cigarette smoking and lung cancer risk; a hospital-based case--control study in Japan.

Authors:  T Marugame; T Sobue; T Nakayama; T Suzuki; H Kuniyoshi; K Sunagawa; K Genka; N Nishizawa; S Natsukawa; O Kuwahara; E Tsubura
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

10.  Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography.

Authors:  Y Toyoda; T Nakayama; Y Kusunoki; H Iso; T Suzuki
Journal:  Br J Cancer       Date:  2008-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.